OWP
TNGX icon

Old Well Partners’s Tango Therapeutics TNGX Stock Holding History

Old Well Partners’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,400
Closed -$182K – 41
2023
Q4 		$182K Buy
+18,400
New +$160K 0.16% 39
2022
Q1 		– Sell
-11,554
Closed -$126K – 43
2021
Q4 		$126K Hold
11,554
– – 0.08% 35
2021
Q3 		$149K Hold
11,554
– – 0.08% 33
2021
Q2 		$131K Buy
+11,554
New +$130K 0.06% 33

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Old Well Partners's TNGX Position: Q1 2024 in Review

Old Well Partners sold out of Tango Therapeutics (TNGX) in Q1 2024, closing a stake of 18,400 shares — an estimated $182K sold.

Old Well Partners first reported a position in TNGX in Q2 2021 and held it in 4 quarters. The position peaked at $182K in Q4 2023. 126 funds tracked by Wall St. Rank hold TNGX as of Q1 2024.

  • Old Well Partners reported no remaining Tango Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Old Well Partners sold 18,400 Tango Therapeutics shares in Q1 2024, an estimated $182K.
  • Old Well Partners first reported a position in Tango Therapeutics in Q2 2021 and held it in 4 quarters.
  • Old Well Partners's Tango Therapeutics position peaked at $182K in Q4 2023.
  • 126 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2024.

Based on Old Well Partners's 13F filing for Q1 2024, filed 15 May 2024.